GLP-1SM (SEMA)

Overview

Aurex GLP-1 SEMA (Semaglutide) is a peptide known for its effectiveness in promoting weight loss and improving glycemic control. As a GLP-1 receptor agonist, it enhances insulin secretion, suppresses appetite, and slows gastric emptying. This peptide is widely studied for its potential in managing type 2 diabetes and obesity, offering a comprehensive approach to metabolic health and weight management.

Key Features & Benefits

• Enhanced Stability & Half-Life: The structural modifications significantly increase metabolic stability, allowing for prolonged GLP-1 receptor activation over extended study periods.
• Weight Management Research: A primary compound for studying appetite suppression, energy expenditure, and fat loss mechanisms.
• Glycemic Control Studies: Facilitates investigation into insulin secretion and blood glucose regulation, providing insights into diabetes management.
• High-Purity Research Grade: Synthesized to ≥ 99% purity (HPLC verified), ensuring reliable and reproducible experimental outcomes.

Primary Research Applications

• Study of appetite regulation and its effects on energy balance and weight loss.
• Research into the mechanisms of insulin secretion and glucose homeostasis.
• Investigation of GLP-1’s role in improving metabolic health and reducing obesity-related complications.
• Long-term models examining the benefits of sustained GLP-1 receptor activation.

Product Specifications

• Unit Size: 10mg, 20mg, 30mg
• Compound: GLP-1SM (Modified Glucagon-Like Peptide-1 analog)
• Purity: ≥ 99% (HPLC verified)
• Form: Lyophilized (freeze-dried) powder
• Storage: For maximum stability, store in a cool, dry place. Refrigeration is recommended for long-term storage

Important Notice

This product is intended for laboratory research and in-vitro study only. It is not for human or veterinary consumption, nor is it a drug or supplement. GLP-1SM is a potent peptide for metabolic research and must be handled by qualified professionals using appropriate safety protocols.